Glaukos Shares Outstanding 2014-2025 | GKOS
Glaukos shares outstanding history from 2014 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- Glaukos shares outstanding for the quarter ending September 30, 2025 were 0.057B, a 4.29% increase year-over-year.
- Glaukos 2024 shares outstanding were 0.053B, a 8.92% increase from 2023.
- Glaukos 2023 shares outstanding were 0.048B, a 2.08% increase from 2022.
- Glaukos 2022 shares outstanding were 0.047B, a 2.2% increase from 2021.
|
Glaukos Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 53 |
| 2023 | 48 |
| 2022 | 47 |
| 2021 | 46 |
| 2020 | 44 |
| 2019 | 41 |
| 2018 | 35 |
| 2017 | 34 |
| 2016 | 36 |
| 2015 | 17 |
| 2014 | 2 |
| 2013 | 2 |
|
Glaukos Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025-09-30 | 57 |
| 2025-06-30 | 57 |
| 2025-03-31 | 57 |
| 2024-12-31 | 53 |
| 2024-09-30 | 55 |
| 2024-06-30 | 51 |
| 2024-03-31 | 50 |
| 2023-12-31 | 48 |
| 2023-09-30 | 49 |
| 2023-06-30 | 48 |
| 2023-03-31 | 48 |
| 2022-12-31 | 47 |
| 2022-09-30 | 48 |
| 2022-06-30 | 47 |
| 2022-03-31 | 50 |
| 2021-12-31 | 46 |
| 2021-09-30 | 49 |
| 2021-06-30 | 46 |
| 2021-03-31 | 46 |
| 2020-12-31 | 44 |
| 2020-09-30 | 45 |
| 2020-06-30 | 44 |
| 2020-03-31 | 44 |
| 2019-12-31 | 41 |
| 2019-09-30 | 37 |
| 2019-06-30 | 36 |
| 2019-03-31 | 36 |
| 2018-12-31 | 35 |
| 2018-09-30 | 36 |
| 2018-06-30 | 35 |
| 2018-03-31 | 35 |
| 2017-12-31 | 34 |
| 2017-09-30 | 38 |
| 2017-06-30 | 34 |
| 2017-03-31 | 38 |
| 2016-12-31 | 36 |
| 2016-09-30 | 37 |
| 2016-06-30 | 36 |
| 2016-03-31 | 36 |
| 2015-12-31 | 17 |
| 2015-09-30 | 32 |
| 2015-06-30 | 3 |
| 2015-03-31 | 2 |
| 2014-12-31 | 2 |
| 2014-09-30 | 2 |
| 2014-06-30 | 2 |
| 2014-03-31 | 2 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $6.244B | $0.383B |
| Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $215.585B | 25.62 |
| Intuitive Surgical (ISRG) | United States | $199.284B | 77.97 |
| IDEXX Laboratories (IDXX) | United States | $56.042B | 55.66 |
| Edwards Lifesciences (EW) | United States | $48.699B | 32.65 |
| Alcon (ALC) | Switzerland | $39.563B | 26.74 |
| IQVIA Holdings (IQV) | United States | $37.963B | 21.17 |
| Mettler-Toledo (MTD) | United States | $28.719B | 33.60 |
| DexCom (DXCM) | United States | $26.350B | 36.32 |
| STERIS (STE) | Ireland | $25.404B | 26.23 |
| Waters (WAT) | United States | $23.565B | 31.17 |
| Hologic (HOLX) | United States | $16.680B | 17.52 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.919B | 0.00 |
| Penumbra (PEN) | United States | $11.869B | 83.49 |
| Globus Medical (GMED) | United States | $11.754B | 24.67 |
| Masimo (MASI) | United States | $7.508B | 24.06 |
| Sysmex ADR (SSMXY) | Japan | $5.917B | 18.80 |
| Teleflex (TFX) | United States | $5.767B | 9.19 |
| TransMedics (TMDX) | United States | $4.484B | 53.12 |
| LivaNova (LIVN) | United Kingdom | $3.498B | 18.90 |
| Veracyte (VCYT) | United States | $3.425B | 39.04 |
| Alphatec Holdings (ATEC) | United States | $3.105B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.521B | 11.83 |
| Elekta AB (EKTAY) | Sweden | $2.116B | 19.79 |
| Artivion (AORT) | United States | $2.094B | 96.11 |
| PROCEPT BioRobotics (PRCT) | United States | $1.995B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.838B | 16.05 |
| UFP Technologies (UFPT) | United States | $1.649B | 21.77 |
| Tandem Diabetes Care (TNDM) | United States | $1.454B | 0.00 |
| AxoGen (AXGN) | United States | $1.384B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.285B | 0.00 |
| IRadimed (IRMD) | United States | $1.237B | 58.91 |
| Integra LifeSciences Holdings (IART) | United States | $1.064B | 5.76 |
| OPKO Health (OPK) | United States | $1.052B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.962B | 0.00 |
| SiBone (SIBN) | United States | $0.815B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.716B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.643B | 37.36 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.627B | 0.00 |
| NeuroPace (NPCE) | United States | $0.559B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.549B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.542B | 10.81 |
| RxSight (RXST) | United States | $0.518B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.471B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.447B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.437B | 12.07 |
| Alpha Tau Medical (DRTS) | Israel | $0.429B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.373B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.350B | 58.35 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.275B | 0.00 |
| 908 Devices (MASS) | United States | $0.238B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.224B | 0.00 |
| CVRx (CVRX) | United States | $0.221B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.220B | 0.00 |
| Inogen (INGN) | United States | $0.188B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.182B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.176B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.161B | 0.00 |
| Solana (HSDT) | United States | $0.157B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.157B | 0.00 |
| LENSAR (LNSR) | United States | $0.138B | 0.00 |
| Accuray (ARAY) | United States | $0.122B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.110B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.104B | 0.00 |
| Hyperfine (HYPR) | United States | $0.101B | 0.00 |
| Neuronetics (STIM) | United States | $0.091B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.088B | 0.00 |
| DarioHealth (DRIO) | United States | $0.086B | 0.00 |
| InspireMD (NSPR) | United States | $0.080B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.073B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.066B | 0.00 |
| Spectral AI (MDAI) | United States | $0.052B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.051B | 0.00 | |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Envoy Medical (COCH) | United States | $0.024B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.018B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.015B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.014B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| NexGel (NXGL) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.24 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |